|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Loss | |||||
| Adjustments required to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Remeasurement of warrants liability | |||||
| Issuance cost allocated to warrants liability | |||||
| Change in accrued interest on bank deposits | |||||
| Change in marketable securities | |||||
| Share-based compensation | |||||
| Realization of investment in non-marketable equity securities | |||||
| Capital gain, net | |||||
| Foreign exchange gain, net | |||||
| Change in prepaid expenses and other assets | |||||
| Change in trade receivables, net | |||||
| Change in inventory | |||||
| Change in operating lease assets and liabilities, net | |||||
| Change in trade payables | |||||
| Change in accrued expenses and other liabilities | |||||
| Change in employees and payroll accruals | |||||
| Change in deferred revenues | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of machinery | |||||
| Proceeds from sales of property and equipment | |||||
| Investment in bank deposits | |||||
| Withdrawal of bank deposits | |||||
| Investment in restricted deposits | |||||
| Withdrawal of restricted deposits | |||||
| Release of restricted deposits | |||||
| Investment in marketable securities | |||||
| Proceeds from sales and maturities of marketable securities | |||||
| Proceeds from sale of non-marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Cash received from Transactions, net of issuance cost | |||||
| Issuance of ordinary shares and warrants, net of issuance costs | |||||
| Issuance of ordinary shares, net of paid issuance costs | |||||
| Proceeds from exercise of shares options | |||||
| Repayment of loans | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at the beginning of the year | |||||
| Cash, cash equivalents and restricted cash at the end of the year | |||||
| Supplementary disclosure of cash flows activities: | |||||
| (1) Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes | |||||
| (2) Non-cash transactions: | |||||
| Conversion of preferred shares to ordinary shares | |||||
| Purchase of property and equipment | |||||
| Reclassification from property and equipment, net to inventory | |||||
| Reclassification of warrants liability to equity | |||||
| Issuance cost paid in equity | |||||
| Issuance cost to be paid | |||||
| Exercise of shares options | |||||
| Right-of-use assets recognized with corresponding lease liabilities | |||||
| (3) Cash, cash equivalents and restricted cash at the end of the year: | |||||
| Cash and cash equivalents | |||||
| Short-term restricted cash | |||||
Loading...